Heather Chambless Herrington, MD | |
111 Colchester Ave, Burlington, VT 05401-1473 | |
(802) 847-2700 | |
Not Available |
Full Name | Heather Chambless Herrington |
---|---|
Gender | Female |
Speciality | Otolaryngology |
Experience | 18 Years |
Location | 111 Colchester Ave, Burlington, Vermont |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679607170 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | 042.0012412 (Vermont) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
Porter Hospital, Inc | Middlebury, VT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Vermont Medical Center Inc | 3779491071 | 994 |
News Archive
The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.
A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
› Verified 4 days ago
Entity Name | University Of Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.
A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
› Verified 4 days ago
Entity Name | Porter Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134457013 PECOS PAC ID: 1850365180 Enrollment ID: O20050919000862 |
News Archive
The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.
A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
› Verified 4 days ago
Entity Name | Central Vermont Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023028784 PECOS PAC ID: 9335138817 Enrollment ID: O20051220000393 |
News Archive
The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.
A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Heather Chambless Herrington, MD 19 Kingsland Ter, Burlington, VT 05401-5501 Ph: () - | Heather Chambless Herrington, MD 111 Colchester Ave, Burlington, VT 05401-1473 Ph: (802) 847-2700 |
News Archive
The American Center for Law and Justice (ACLJ), focusing on constitutional law, said today despite President Obama's insistence that "no federal dollars will be used to fund abortions" – the fact is that such a proclamation does not guarantee that abortion won't become a mandatory health care "benefit" under health care reform.
A new discovery could lead to treatments which turn off the inflammation in the lungs caused by influenza and other infections, according to a study published in the journal Nature Immunology.
"Declining malaria deaths in Africa and progress toward an effective malaria vaccine are raising hopes the disease will soon be eradicated worldwide," but "researchers at the annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH) in Philadelphia, Pennsylvania, [on Monday] unveiled a new global malaria map that raises new concerns about the disease," VOA News writes.
RedHill Biopharma Ltd., a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.
› Verified 4 days ago
Tamara Rimash, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. George Kurien, MD FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Erin Tracy Ostby, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave Fl 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. William John Brundage, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-4535 Fax: 802-847-8198 | |
Dr. Donna Jean Millay, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4 Otolaryngology, Burlington, VT 05401 Phone: 802-847-4537 Fax: 802-847-8198 | |
Dr. Gary Patrick Landrigan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, West Pavilion-level 4, Burlington, VT 05401 Phone: 802-847-9393 Fax: 802-847-8198 |